Source: Health Products and Food Branch (CA) Revision Year: 2019
Flonase Allergy Relief – Fluticasone propionate aqueous nasal spray USP.
| Route of Administration | Dosage Form/Strength | Nonmedicinal Ingredients |
|---|---|---|
| Intranasal | Nasal spray/50 mcg | benzalkonium chloride, dextrose, microcrystalline cellulose and carboxymethylcellulose sodium, phenylethyl alcohol, polysorbate 80, and purified water. |
Flonase Allergy Relief is an aqueous suspension of microfine fluticasone propionate (0.05% w/w) for topical administration to the nasal mucosa by means of a metering, atomising spray pump. Each 100 mg of spray delivered by the nasal adaptor (1 actuation), contains 50 mcg of fluticasone propionate.
Flonase Allergy Relief contains micronised fluticasone propionate 0.05% w/w and the following non-medicinal ingredients: benzalkonium chloride, dextrose, microcrystalline cellulose and carboxymethylcellulose sodium, phenylethyl alcohol, polysorbate 80, and purified water.
Flonase Allergy Relief is available in an amber glass bottle containing sufficient formulation for 60 or 120 metered sprays (8 g or 16 g net weight).
| Marketing Informations | Authorization Dates |
|---|---|
|
Authorization holder:
GlaxoSmithKline Consumer Healthcare Inc., 7333 Mississauga Road, Mississauga, Ontario, L5N 6L4 226709 |
Date of revision:
July 22, 2019 |
| Drug | Countries | |
|---|---|---|
| FLONASE | Canada, Spain, Poland, Romania, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
